University Hospital of Northern Norway
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Flaegstad, Trond
NOPHO-DBH, NCT01828489 / 2012-002934-35: Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years

Recruiting
3
300
Europe, RoW
Randomisation course 1 mitoxantrone versus DaunoXome, Randomisation course 2 ADxE versus FLADx
Vastra Gotaland Region
Pediatric Acute Myeloblastic Leukemia
03/18
03/23
NCT01728155: European Low and Intermediate Risk Neuroblastoma Protocol

Completed
3
685
Europe, RoW
chemotherapy
Instituto de Investigacion Sanitaria La Fe
LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES
12/22
 
HR-NBL2, NCT04221035 / 2019-001068-31: High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Recruiting
3
800
Europe, RoW
Vincristine, L01CA02, Carboplatin, LO1XA02, Etoposide, L01CB01, Vindesine, L01CA03, Dacarbazine, L01AX04, Ifosfamide, Doxorubicin, L01DB01, Busulfan, L01AB01, Melphalan, L01AA03, Thiotepa, L01AC01, Radiotherapy, Dinutuximab Beta, L01XC16, Cisplatin, L01XA01, Temozolomide 100 MG, Irinotecan, Cyclophosphamid
Gustave Roussy, Cancer Campus, Grand Paris, PHRC, Solving Kids' Cancer Europe, Neuroblastoma UK, , BSPHO, Instituto de Investigación Sanitaria La Fe, Deutsche Krebshilfe
High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
11/26
11/32
NOR-NEC, NCT06757582: Necrotizing Enterocolitis and Bowel Perforation in Very Preterm Infants - Long-term Follow up

Not yet recruiting
N/A
150
Europe
University Hospital of North Norway
Necrotizing Enterocolitis, Intestinal Perforation, Premature Infant Disease
08/26
08/27

Download Options